Study of the use of antidepressants for depression in dementia: the HTA-SADD trial - a multicentre, randomised, double-bind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine

S Banerjee; J Hellier; R Romeo; M Dewey; M Knapp; C Ballard; R Baldwin; P Bentham; C Fox; C Holmes; C Katona; C Lawton; J Lindesay; G Livingston; N McCrae; E Moniz-Cook; J Murray; S Nurock; M Orrell; J O'Brien; M Poppe; A Thomas; R Walwyn; K Wilson; A Burns

doi:10.3310/hta17070

Study of the use of antidepressants for depression in dementia: the HTA-SADD trial - a multicentre, randomised, double-bind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine

S Banerjee, J Hellier, R Romeo, M Dewey, M Knapp, C Ballard, R Baldwin, P Bentham, C Fox, C Holmes, C Katona, C Lawton, J Lindesay, G Livingston, N McCrae, E Moniz-Cook, J Murray, S Nurock, M Orrell, J O'BrienM Poppe, A Thomas, R Walwyn, K Wilson, A Burns

Research output: Contribution to journal › Article › peer-review

90 Citations (Scopus)

Original language	English
Pages (from-to)	1-166
Number of pages	166
Journal	Health Technology Assessment
Volume	17
Issue number	7
DOIs	https://doi.org/10.3310/hta17070
Publication status	Published - Feb 2013

Access to Document

10.3310/hta17070

Cite this

Banerjee, S., Hellier, J., Romeo, R., Dewey, M., Knapp, M., Ballard, C., Baldwin, R., Bentham, P., Fox, C., Holmes, C., Katona, C., Lawton, C., Lindesay, J., Livingston, G., McCrae, N., Moniz-Cook, E., Murray, J., Nurock, S., Orrell, M., ... Burns, A. (2013). Study of the use of antidepressants for depression in dementia: the HTA-SADD trial - a multicentre, randomised, double-bind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine. Health Technology Assessment, 17(7), 1-166. https://doi.org/10.3310/hta17070

@article{45f6873ce9d0437597d8d52cc932ff6e,

title = "Study of the use of antidepressants for depression in dementia: the HTA-SADD trial - a multicentre, randomised, double-bind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine",

author = "S Banerjee and J Hellier and R Romeo and M Dewey and M Knapp and C Ballard and R Baldwin and P Bentham and C Fox and C Holmes and C Katona and C Lawton and J Lindesay and G Livingston and N McCrae and E Moniz-Cook and J Murray and S Nurock and M Orrell and J O'Brien and M Poppe and A Thomas and R Walwyn and K Wilson and A Burns",

year = "2013",

month = feb,

doi = "10.3310/hta17070",

language = "English",

volume = "17",

pages = "1--166",

journal = "Health Technology Assessment",

issn = "1366-5278",

publisher = "National Co-ordinating Centre for HTA",

number = "7",

}

Banerjee, S, Hellier, J, Romeo, R, Dewey, M, Knapp, M, Ballard, C, Baldwin, R, Bentham, P, Fox, C, Holmes, C, Katona, C, Lawton, C, Lindesay, J, Livingston, G, McCrae, N, Moniz-Cook, E, Murray, J, Nurock, S, Orrell, M, O'Brien, J, Poppe, M, Thomas, A, Walwyn, R, Wilson, K & Burns, A 2013, 'Study of the use of antidepressants for depression in dementia: the HTA-SADD trial - a multicentre, randomised, double-bind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine', Health Technology Assessment, vol. 17, no. 7, pp. 1-166. https://doi.org/10.3310/hta17070

Study of the use of antidepressants for depression in dementia: the HTA-SADD trial - a multicentre, randomised, double-bind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine. / Banerjee, S; Hellier, J; Romeo, R et al.

In: Health Technology Assessment, Vol. 17, No. 7, 02.2013, p. 1-166.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Study of the use of antidepressants for depression in dementia: the HTA-SADD trial - a multicentre, randomised, double-bind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine

AU - Banerjee, S

AU - Hellier, J

AU - Romeo, R

AU - Dewey, M

AU - Knapp, M

AU - Ballard, C

AU - Baldwin, R

AU - Bentham, P

AU - Fox, C

AU - Holmes, C

AU - Katona, C

AU - Lawton, C

AU - Lindesay, J

AU - Livingston, G

AU - McCrae, N

AU - Moniz-Cook, E

AU - Murray, J

AU - Nurock, S

AU - Orrell, M

AU - O'Brien, J

AU - Poppe, M

AU - Thomas, A

AU - Walwyn, R

AU - Wilson, K

AU - Burns, A

PY - 2013/2

Y1 - 2013/2

U2 - 10.3310/hta17070

DO - 10.3310/hta17070

M3 - Article

VL - 17

SP - 1

EP - 166

JO - Health Technology Assessment

JF - Health Technology Assessment

SN - 1366-5278

IS - 7

ER -

Banerjee S, Hellier J, Romeo R, Dewey M, Knapp M, Ballard C et al. Study of the use of antidepressants for depression in dementia: the HTA-SADD trial - a multicentre, randomised, double-bind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine. Health Technology Assessment. 2013 Feb;17(7):1-166. doi: 10.3310/hta17070